FTFinancial Times·2dHealth
score+0.60
Six-year-olds: Novo’s new frontier for weight-loss drugs
Original
Six-year-olds: Novo’s new frontier for weight-loss drugs
“The headline frames a clinical trial success with high efficacy statistics, presenting a positive medical development for a young demographic.”